Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection

被引：13

作者：

Romani, Lorenza ^{[1
]}

Carducci, Francesca Ippolita Calo ^{[1
]}

Chiurchiu, Sara ^{[1
]}

Cursi, Laura ^{[1
]}

De Luca, Maia ^{[1
]}

Di Giuseppe, Martina ^{[1
]}

Krzysztofiak, Andrzej ^{[1
]}

Lancella, Laura ^{[1
]}

Palma, Paolo ^{[2
,3
]}

Vallesi, Leonardo ^{[4
]}

Corsetti, Tiziana ^{[4
]}

Campana, Andrea ^{[5
]}

Nicastri, Emanuele ^{[6
]}

Rossi, Paolo ^{[3
,7
]}

Bernardi, Stefania ^{[1
]}

机构：

[1] Bambino Gesu Pediat Hosp, Immunol & Infect Dis Unit, IRCCS, I-00165 Rome, Italy

[2] Bambino Gesu Pediat Hosp, Res Unit Congenital & Perinatal Infect, IRCCS, I-00165 Rome, Italy

[3] Univ Roma Tor Vergata, Dept Syst Med, Chair Pediat, I-00133 Rome, Italy

[4] Bambino Gesu Pediat Hosp, Hosp Pharm Unit, IRCCS, I-00165 Rome, Italy

[5] Bambino Gesu Pediat Hosp, Dept Pediat, IRCCS, I-00165 Rome, Italy

[6] IRCCS, Natl Inst Infect Dis, I-00149 Rome, Italy

[7] Bambino Gesu Pediat Hosp, Acad Dept Pediat, IRCCS, I-00165 Rome, Italy

来源：

CHILDREN-BASEL | 2022年 / 9卷 / 03期

关键词：

COVID-19; monoclonal antibody; children;

D O I：

10.3390/children9030369

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Monoclonal antibody therapies for COVID-19 have been frequently used in adults, whereas there are little data regarding the safety or efficacy of monoclonal antibody treatments in pediatric patients affected by COVID-19. We report our experience in the administration of mAb as a treatment for SARS-CoV-2 infection in children aged from 24 days to 18 years old.

引用

页数：6

共 50 条

[1] SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
Wolfe, Ian D.
Patel, Sameer J.
CLINICAL THERAPEUTICS, 2021, 43 (06) : E157 - E162
[2] SARS-CoV-2 infection in children
Cokugras, Haluk
Onal, Pinar
TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2020, 55 (02): : 95 - 102
[3] Neutralizing antibodies for SARS-CoV-2 infection
Berenguer, Juan
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 16 - 19
[4] Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
Kumar, Sonu
Dutta, Debrupa
Ravichandiran, Velayutham
Sukla, Soumi
3 BIOTECH, 2022, 12 (09)
[5] Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
Sonu Kumar
Debrupa Dutta
Velayutham Ravichandiran
Soumi Sukla
3 Biotech, 2022, 12
[6] Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection
Bruzzesi, Elena
Ranzenigo, Martina
Castagna, Antonella
Spagnuolo, Vincenzo
NEW MICROBIOLOGICA, 2021, 44 (03) : 135 - 144
[7] Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection
Romani, L.
Del Chierico, F.
Pane, S.
Ristori, M. V.
Pirona, I.
Guarrasi, V.
Cotugno, N.
Bernardi, S.
Lancella, L.
Perno, C. F.
Rossi, P.
Villani, A.
Campana, A.
Palma, P.
Putignani, L.
MICROBIOLOGY SPECTRUM, 2024, 12 (03):
[8] Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series
Rau, Cornelius
Auer-Hackenberg, Lorenz
Deubzer, Hedwig E.
Schwabel, Elisabeth
Jaros, Maria
Diederichs, Antonia
Lehrnbecher, Thomas
Holm, Mette
von Linstow, Marie-Louise
Martin, Luise
Dinges, Sarah Svenja
Rothensteiner, Maria
Siepermann, Meinolf
Strenger, Volker
von Both, Ulrich
Teig, Norbert
Brinkmann, Folke
Leeb, Franziska
Zeitlinger, Markus
Kobbe, Robin
Goetzinger, Florian
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (02) : 125 - 129
[9] Update on SARS-CoV-2 infection in children
Martins, Marlos Melo
Prata-Barbosa, Arnaldo
Ledo Alves da Cunha, Antonio Jose
PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2021, 41 (01) : 56 - 64
[10] Monoclonal neutralizing antibodies against SARS-COV-2 S protein
Cheng, Lin-Dong
Li, Ping
Lin, Yan-Chen
Hu, Hui-Xiu
Zhang, Ying
Li, Hou-Feng
Huang, Jing
Tan, Li
Ma, Ning
Xia, Deng-Yun
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (02): : 681 - 689

← 1 2 3 4 5 →